Forward Pharma A/S

FWPAYOTCHealthcare

$300.00

$-100.50(-25.09%)

Market Cap$7445700

P/E Ratio—

52W High$882.85626

52W Low$200.0

Avg Volume10

Open$300.00

Beta1.02

Earnings Financials Revenue

Forward Pharma A/S (FWPAY) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

FWPAY · earnings · updated Jun 9, 2026

Latest Earnings

Q2 FY2017Report Date: Apr 18, 2017

EPS Actual

-$1.75

Est. -$2.12 · +17.4%

Revenue

—

Fiscal Period

Q2 FY2017

FY ends December

Report Date

Apr 18, 2017

After Market Close

▲ Beat EPS✓ 2-Quarter EPS Beat Streak

FWPAY reports quarterly as a OTC-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.

Next Earnings Date

Days Away

days

Expected Date

Sep 1, 2026

Fiscal Period

Q3 FY2026

Release Time

◌ Time TBD (Unconfirmed)

EPS Est.

—

Days Away84

Expected DateSep 1, 2026

Fiscal PeriodQ3 FY2026

Release TimeTime TBD (Unconfirmed)

EPS Est.—

EPS & Revenue vs. Estimates

Actual (Beat)

Actual (Miss)

Estimated

Earnings History

Period	Report Date	EPS Est.	EPS Actual	EPS Surpr.	Revenue	Rev. Est.	Rev. Surpr.
▲ Q2 FY2017	Apr 18, 2017	-$2.12	-$1.75	+17.4%	—	—	—
▲ Q4 FY2016	Nov 29, 2016	-$2.45	-$1.61	+34.3%	—	—	—
▼ Q3 FY2016	Sep 1, 2016	-$1.84	-$2.24	-21.7%	—	—	—
▼ Q2 FY2016	Jun 2, 2016	-$1.89	-$2.52	-33.3%	—	—	—
▲ Q2 FY2016	Apr 12, 2016	-$2.62	-$1.43	+45.4%	—	—	—
▼ Q4 FY2015	Nov 25, 2015	-$2.24	-$2.38	-6.3%	—	—	—
▼ Q3 FY2015	Sep 8, 2015	-$1.52	-$2.66	-75.0%	—	—	—
— Q2 FY2015	Jun 30, 2015	—	-$757.13	—	—	—	—

Q2 FY2017

Apr 18, 2017Beat

EPS Actual

-$1.75

EPS Est.

-$2.12

EPS Surpr.

+17.4%

Revenue

—

Q4 FY2016

Nov 29, 2016Beat

EPS Actual

-$1.61

EPS Est.

-$2.45

EPS Surpr.

+34.3%

Revenue

—

Q3 FY2016

Sep 1, 2016Miss

EPS Actual

-$2.24

EPS Est.

-$1.84

EPS Surpr.

-21.7%

Revenue

—

Q2 FY2016

Jun 2, 2016Miss

EPS Actual

-$2.52

EPS Est.

-$1.89

EPS Surpr.

-33.3%

Revenue

—

Q2 FY2016

Apr 12, 2016Beat

EPS Actual

-$1.43

EPS Est.

-$2.62

EPS Surpr.

+45.4%

Revenue

—

Q4 FY2015

Nov 25, 2015Miss

EPS Actual

-$2.38

EPS Est.

-$2.24

EPS Surpr.

-6.3%

Revenue

—

Q3 FY2015

Sep 8, 2015Miss

EPS Actual

-$2.66

EPS Est.

-$1.52

EPS Surpr.

-75.0%

Revenue

—

Q2 FY2015

Jun 30, 2015

EPS Actual

-$757.13

EPS Est.

—

EPS Surpr.

—

Revenue

—

No analyst estimates available for FWPAY.

Earnings Price Reaction

Closing price one trading day before vs. one trading day after each earnings release.

Period	Report Date	EPS Beat/Miss	Price Before	Price After	1D Reaction
▲ Q2 FY2017	Apr 18, 2017	+17.4%	$46,223.33	$45,966.67	-0.56%
▲ Q4 FY2016	Nov 29, 2016	+34.3%	$52,080.00	$51,216.67	-1.66%
▼ Q3 FY2016	Sep 1, 2016	-21.7%	$45,990.00	$44,520.00	-3.20%
▼ Q2 FY2016	Jun 2, 2016	-33.3%	$48,043.33	$49,910.00	+3.89%
▲ Q2 FY2016	Apr 12, 2016	+45.4%	$40,250.00	$41,370.00	+2.78%
▼ Q4 FY2015	Nov 25, 2015	-6.3%	$47,903.33	$51,683.33	+7.89%
▼ Q3 FY2015	Sep 8, 2015	-75.0%	$59,406.67	$62,638.33	+5.44%
— Q2 FY2015	Jun 30, 2015	—	$91,000.00	$88,783.34	-2.44%

Q2 FY2017-0.56%

Report Date

Apr 18, 2017

EPS Beat/Miss

+17.4%

Price Before

$46,223.33

Price After

$45,966.67

Q4 FY2016-1.66%

Report Date

Nov 29, 2016

EPS Beat/Miss

+34.3%

Price Before

$52,080.00

Price After

$51,216.67

Q3 FY2016-3.20%

Report Date

Sep 1, 2016

EPS Beat/Miss

-21.7%

Price Before

$45,990.00

Price After

$44,520.00

Q2 FY2016+3.89%

Report Date

Jun 2, 2016

EPS Beat/Miss

-33.3%

Price Before

$48,043.33

Price After

$49,910.00

Q2 FY2016+2.78%

Report Date

Apr 12, 2016

EPS Beat/Miss

+45.4%

Price Before

$40,250.00

Price After

$41,370.00

Q4 FY2015+7.89%

Report Date

Nov 25, 2015

EPS Beat/Miss

-6.3%

Price Before

$47,903.33

Price After

$51,683.33

Q3 FY2015+5.44%

Report Date

Sep 8, 2015

EPS Beat/Miss

-75.0%

Price Before

$59,406.67

Price After

$62,638.33

Q2 FY2015-2.44%

Report Date

Jun 30, 2015

EPS Beat/Miss

—

Price Before

$91,000.00

Price After

$88,783.34

Avg Beat Reaction+0.19%

Avg Miss Reaction+3.50%

Beat Rate3 / 8 quarters

Largest Move+7.89% (Q4 FY2015)

Data: FMP /historical-price-eod/full · field: close

About Earnings & Data Methodology

Forward Pharma A/S (FWPAY) most recently reported earnings on April 18, 2017 for Q2 FY2017, posting EPS of $-1.75 — beating the analyst consensus of $-2.12 by +17.4%. FWPAY has beaten EPS estimates for 2 consecutive quarters. The next FWPAY earnings date is expected around September 1, 2026.

Each quarter, investors track FWPAY earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. FWPAY revenue tab →

Earnings Glossary

EPS (Earnings Per Share)

Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.

Earnings Surprise %

(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.

Beat / Miss / In-Line

Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.

BMO / AMC

Before Market Open / After Market Close. Two windows when companies typically release results.

Fiscal Quarter

FWPAY's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.

Analyst Consensus

Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.

Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Revenue Price history Financial statements Forecast Dividends Market cap

Frequently asked questions

FWPAY earnings · 5 questions

Forward Pharma A/S's next earnings report is expected around September 1, 2026. FWPAY typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; FWPAY historically reports after market close (AMC).

FWPAY earnings datewhen is FWPAY earningsFWPAY next earnings datewhen does FWPAY report earningsFWPAY earnings calendar

▸ Source: FMP · Forward Pharma A/S SEC filings · US GAAP · Forward Pharma A/S SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026